For example, BAG3 Cys151Arg was proposed to serve as an important genetic modifier variant in DCM, by modulating risk on the DCM-HCM spectrum, and impacting DCM risk in carriers of pathogenic truncating titin variants (Park et al., 2024). Here, TTN is linked to familial dilated cardiomyopathy.